Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05981131 · ClinicalTrials.gov registry record

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

A clinical trial of Non-muscle Invasive Bladder Cancer, sponsored by ImmunityBio.

Active
Registry status
6
Enrollment target
1
Study location

NCT05981131 is a study of Non-muscle Invasive Bladder Cancer that is active but no longer recruiting, run by ImmunityBio. The registered enrollment target is 6 participants, below the 233-participant average among 28 other Non-muscle Invasive Bladder Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05981131, a study of Non-muscle Invasive Bladder Cancer, is active but no longer recruiting, sponsored by ImmunityBio.

ACTIVE NOT RECRUITING
Registry status
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.

Conditions Studied

Non-muscle Invasive Bladder Cancer

Interventions

  • DRUG N803 plus Bacillus Calmette-Guerin (BCG)

Study Locations (1)

Hawaii

  • Island Urology - Honolulu

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-08-17
Est. Completion 2033-08-30

Sponsor

ImmunityBio

46 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05981131

The ClinicalTrials.gov registry entry for NCT05981131 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 233-participant average among 28 other Non-muscle Invasive Bladder Cancer trials with a reported enrollment target (97% lower). The listed sponsor is ImmunityBio, which has 46 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Non-muscle Invasive Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which N803 plus Bacillus Calmette-Guerin (BCG) is the first listed.

NCT05981131 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.

Frequently Asked Questions

What is clinical trial NCT05981131 about?

NCT05981131 is a clinical study titled "Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)". The purpose of this clinical trial is to obtain long-term follow-up information and status of bladder cancer for patients who received study treatment in the QUILT-2.005 study.

What is the current status of trial NCT05981131?

This trial is currently active not recruiting. The enrollment target is 6 participants. The study started on 2023-08-17. Estimated completion is 2033-08-30.

What conditions does trial NCT05981131 study?

This clinical trial studies the following conditions: Non-muscle Invasive Bladder Cancer.

What interventions are being tested in trial NCT05981131?

The interventions under investigation include: N803 plus Bacillus Calmette-Guerin (BCG) (DRUG).

Who is sponsoring clinical trial NCT05981131?

This trial is sponsored by ImmunityBio, which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05981131 being conducted?

This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Non-muscle Invasive Bladder Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Non-muscle Invasive Bladder Cancer

All registered trials for this condition

Hawaii

All trials with a study site in Hawaii

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.